Biopharmaceuticals and Biosimilars

Biopharmaceuticals have become a cornerstone of modern medicine. This track examines the development, production, and regulatory challenges of biopharmaceuticals and biosimilars.

Topics:

  • Monoclonal Antibody Therapeutics
  • Regulatory Pathways for Biosimilars
  • Bioprocess Optimization
  • Emerging Biopharmaceutical Markets

    Related Conference of Biopharmaceuticals and Biosimilars

    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany
    September 21-22, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    November 16-17, 2026

    8th International Conference on Biochemistry

    Tokyo, Japan
    November 25-26, 2026

    30th World Congress on Biotechnology

    Rome, Italy
    December 01-02, 2026

    21st World Congress on Biomarkers, Cancer Therapy & Clinical Research

    Dubai, UAE
    January 18-19, 2027

    7th Annual Congress on Antibiotics and Bacterial Infections

    Paris, France
    March 15-16, 2027

    8th Annual Congress on Biosimilars and Future Biotherapeutics

    San Francisco, USA
    April 27-28, 2027

    30th European Biotechnology Congress

    Paris, France

    Biopharmaceuticals and Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in